Straits Times Index
3,308.18 +8.18 (+0.25%) Nikkei
38,639.77 +6.75 (+0.02%) Hang Seng
18,004.98 -330.34 (-1.80%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,542.68 -792.81 (-1.21%) CMC Crypto 200
1,351.85 -30.82 (-2.23%)
TMCI Sep 2024 25.000 call
| Previous close | 0.1300 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 1.0000 |
| Strike | 25.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.1300 - 0.1300 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
GlobeNewswireTreace to Present at Truist Securities MedTech Conference
Tuesday, June 18, 2024 at 8:00 am Eastern TimePONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside
GuruFocus.comDirector Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
GuruFocus.comDirector Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI)
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
